Genenta Science (GNTA) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation and amortization	186K
Amortization of deferred financing costs and debt discount	27.55M
Share-based compensation	405K
Change in fair value - conversion feature liability (Note 6)	-1.2M
Change in fair value - warrant liability (Note 6)	20.41M
Receivable on sale of New Jersey tax losses	0
Inventory	7K
Prepaid expenses and other current assets	31K
Accounts payable and accrued expenses	7.63M
Net cash used in operating activities	-14.41M
Purchase of property and equipment	-140K
Interest on restricted cash	-3K
Net cash used in investing activities	-143K
Issuance of note payable for financing insurance policies	544K
Repayments of note payable for financing insurance policies	-581K
Sale of convertible notes net of financing costs	12.34M
Deposits in blocked cash account	-8.47M
Net cash provided by/(used in) financing activities	3.84M
Increase/(decrease) in cash and cash equivalents	-10.72M
Cash and cash equivalents at beginning of period	12.84M
Cash and cash equivalents at end of period	2.12M

Entities mentioned with GNTA

View All Entities